Pituitary

• Editorial

Special issue: Cushing's disease update

Maria Fleseriu

• Open Access

Genetics of Cushing’s disease: from the lab to clinical practice

Marily Theodoropoulou, Martin Reincke

Overnight 1 mg dexamethasone suppression test and 24 h urine free cortisol—accuracy and pitfalls when screening for Cushing’s syndrome

Stephan Petersenn

Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing’s syndrome)

Hershel Raff

• Open Access

How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)

Carla Scaroni, Alessandro Mondin, Filippo Ceccato

• Review

Biochemical testing to differentiate Cushing’s disease from ectopic ACTH syndrome

Amandine Ferriere, Antoine Tabarin

• Open Access
• Review

Modern imaging in Cushing’s disease

W. A. Bashari, D. Gillett, J. MacFarlane, A. S. Powlson, A. G. Kolias, R. Mannion, D. J. Scoffings, I. A. Mendichovszky, J. Jones, H. K. Cheow, O. Koulouri, M. Gurnell

Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation

Pamela S. Jones, Brooke Swearingen

Cushing’s disease: risk of recurrence following trans-sphenoidal surgery, timing and methods for evaluation

Maria Balomenaki, Dimitra A. Vassiliadi, Stylianos Tsagarakis

Pituitary acting drugs: cabergoline and pasireotide

Mônica R. Gadelha, Luiz Eduardo Wildemberg, Ilan Shimon

• Open Access

Cushing’s disease: adrenal steroidogenesis inhibitors

Rosario Pivonello, Chiara Simeoli, Nicola Di Paola, Annamaria Colao

Glucocorticoid receptor blockers

Mark E. Molitch

• Review

Cushing’s disease: role of preoperative and primary medical therapy

Frederic Castinetti

Role of Radiation in the treatment of Cushing Disease

Laurence Katznelson

Cushing’s disease: role of bilateral adrenalectomy

Jérôme Bertherat

• Open Access

Hypercoagulability in Cushing’s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols

Richard A. Feelders, Lynnette K. Nieman

• Open Access

Cardiovascular health and mortality in Cushing’s disease

Amy Coulden, Ross Hamblin, John Wass, Niki Karavitaki

Novel approaches to bone comorbidity in Cushing’s disease: an update

Stefano Frara, Luigi di Filippo, Mauro Doga, Paola Loli, Felipe F. Casanueva, Andrea Giustina

Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing’s disease

Cesar Luiz Boguszewski

Cushing’s disease in children: unique features and update on genetics

Constantine A. Stratakis

• Open Access
• Review

Quality of life impairment after a diagnosis of Cushing’s syndrome

Susan M Webb, Elena Valassi

• Open Access

Pituitary tumor centers of excellence for Cushing’s disease

Marcos Couselo, Stefano Frara, Andrea Giustina, Felipe F. Casanueva